Rationale and design of OPtimising thERapy to prevent Avoidable hospital admissions in Multimorbid older people (OPERAM): a cluster randomised controlled trialLuise Adam, Nicolas Rodondi, Claudio Schneider et al.|BMJ Open|2019Cited by 69
Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolismMartin F. Reiner, Jürg H. Beer, Daniel J. Müller et al.|Thrombosis Research|2018Cited by 40
Omega‐3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolismMartin F. Reiner, Jürg H. Beer, Simona Stivala et al.|Journal of Thrombosis and Haemostasis|2017Cited by 31
P5320Trimethylamine-N-oxide (TMAO) Predicts Total Mortality, but not Recurrent Venous Thromboembolism in Elderly Patients with Acute Venous ThromboembolismMartin F. Reiner, Jürg H. Beer, Deborah Mueller et al.|European Heart Journal|2017Cited by 0